Research Report University Hospital clinical trial SOV03

Abstract

Randomized, open-label, parallel group, multi-center Phase II clinical trial evaluating the effect of adding DCVAC/OvCa to standard chemotherapy in women with 1st relapsed of platinum-resistant epithelial ovarian cancer

Keywords

• platinum-resistant epithelial ovarian cancer
• DCVAC/OvCa